Kioxia TH Tablet is a combination medication containing Etoricoxib 60 mg and Thiocolchicoside 4 mg, formulated for the management of musculoskeletal pain and inflammation associated with conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute musculoskeletal disorders. Etoricoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, provides effective anti-inflammatory and analgesic effects by reducing prostaglandin synthesis, thereby alleviating pain and inflammation with a lower risk of gastrointestinal adverse effects compared to non-selective NSAIDs. Thiocolchicoside, a muscle relaxant with anti-inflammatory properties, acts by modulating glycine and GABA receptors, leading to the relief of muscle spasms and stiffness. The combination of these agents offers synergistic benefits, addressing both inflammatory pain and muscle spasm, improving patient mobility and comfort. Kioxia TH Tablet is indicated for short-term use under medical supervision, with caution advised in patients with cardiovascular risk factors, hepatic or renal impairment, and hypersensitivity to any component. Common side effects may include gastrointestinal discomfort, dizziness, and mild allergic reactions. It is contraindicated during pregnancy and lactation. Patients should adhere to prescribed dosages and consult healthcare professionals before initiating therapy to ensure safety and efficacy.